🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Healthy Volunteers - Male and Female

A Pharmacokinetics and Safety Study of Azvudine Tablets in Subjects With Mild-To-Moderate GFR Decline in Renal Insufficiency and in Healthy Subjects NCT07001436Phase 11 site📍 Beijing Henan Genuine Biotech Co., Ltd. · Tests: Azvudine tablets A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function NCT07315360Phase 14 sites📍 Lake Forest📍 Orlando📍 Tampa Pfizer · Tests: PF-07328948 A Phase 1 Study of CLYM116 in Normal Healthy Volunteers NCT07248865Phase 11 site📍 Brisbane Climb Bio, Inc. · Tests: CLYM116, Placebo A Phase 1 Study of Single and Multiple Ascending Doses of GV-100 NCT07788014Phase 11 site📍 Adelaide Gilva Therapeutics Inc. · Tests: GV-100, Placebo A Methodological Study to Learn More About Kidney Function in Healthy People and in People With Reduced Kidney Function NCT07368712NA1 site📍 Berlin Bayer · Tests: No investigational study intervention Study to Assess the Plasma Concentration of Rilzabrutinib Given as a Tablet to Adult Participants With Severe Renal Impairment Compared to Matched Participants With Normal Renal Function NCT07853131Phase 11 site📍 Hialeah Sanofi · Tests: rilzabrutinib To Evaluate the Effect of Food on the Pharmacokinetics of Y-4 Tablets in Healthy Subjects NCT07013773Phase 11 site📍 Beijing Beijing Tiantan Hospital · Tests: Y-4 tablet A Study to Evaluate the Safety, Tolerability and PK of SK-08 NCT07021157Phase 11 site📍 Hangzhou Consun Pharmaceutical Group · Tests: SK-08, Placebo Effects of Lentil Protein Hydrolysate on Blood Pressure Control, Vascular Function and Exercise Performance NCT06894875NA1 site📍 Melbourne Nuritas Ltd · Tests: Lentil protein hydrolysate, Placebo MCC micro-crystalline cellulose BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants NCT06741072Phase 11 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Biospecimen Collection, Dulbecco''s Phosphate-Buffered Saline, Peptide Vaccine, QS21 Vasopressin and Pain Perception in the Brain NCT03446456Phase 1, Phase 21 site📍 Baltimore University of Maryland, Baltimore · Tests: Arginine vasopressin, Saline, Observational learning, fMRI data aquisition Phase 1a Study Assessing Safety, Tolerability, Pharmacokinetics, and Immunogenicity of PMG1016 NCT07615985Phase 11 site📍 Brisbane Pulmongene Ltd. · Tests: PMG1016 Dose 1, PMG1016 Dose 2, PMG1016 Dose 3, PMG1016 Dose 4 Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging NCT07225114Phase 21 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: contrast agent perflutren lipid, Ultrasound Imaging Evaluating a Mat-Based Biometric Vibration System for Sleep and Daily Recovery NCT07221318NA1 site📍 Miami Florida International University · Tests: Low-frequency whole-body vibration mat Development of an Improved Method of Measuring Total Body Bone Perfusion Using Total-body PET/CT NCT07860346n/a1 site📍 London King's College London · Tests: 1-hour Total Body PET/CT scan using the tracer [18F]-sodium fluoride A Study of MIL116 in Healthy Participants and Patients With IgA Nephropathy. NCT07375758Phase 1, Phase 21 site📍 Beijing Beijing Mabworks Biotech Co., Ltd. · Tests: MIL116, Matching Placebo Effect of Acute Hypoxia on Renal Hemodynamic in Healthy Volunteers, Patients With Diabetes and Patients With Diabetes and Kidney Disease NCT06846034NA1 site📍 Poitiers Poitiers University Hospital · Tests: Hypoxia administration study group, Renal clairance study Pharmacokinetics of Y-4 Tablets With Pregabalin Capsules and Riluzole Tablets in Chinese Healthy Subject NCT06935721Phase 11 site📍 Beijing Beijing Tiantan Hospital · Tests: Y-4 tablet, Pregabalin capsule, Riluzole tablet Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants With Chronic Kidney Disease NCT07235059Phase 12 sites📍 Miami📍 Berlin Novartis Pharmaceuticals · Tests: OJR520, Placebo A Study of ORN252 in Healthy Participants NCT07439796Phase 11 site📍 Herston Orna Therapeutics, Inc. · Tests: ORN252 A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients With C3-Glomerulopathy NCT07483827Phase 117 sites📍 Vienna📍 Brussels📍 Prague eleva GmbH · Tests: CPV-104/Placebo, CPV-104 Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue NCT02379429n/a1 site📍 Bethesda National Cancer Institute (NCI) The Effects of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) on Anxiety Responses and Emotional Regulation NCT07369908NA1 site📍 Chengdu University of Electronic Science and Technology of China · Tests: taVNS on tragus of subjects with high trait anxiety, taVNS on earlobe of subjects with high trait anxiety, taVNS on tra… Blood Flow Restriction (BFR) Training on the Ulnar Collateral Ligament (UCL) NCT06664827NA1 site📍 Houston The Methodist Hospital Research Institute · Tests: Delfi PTS Blood Flow Restriction Tourniquet System A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide NCT07793929Phase 12 sites📍 Orlando📍 San Antonio Kailera · Tests: Ribupatide Urinary Vitamin C Loss in Diabetic Subjects NCT00071526n/a1 site📍 Bethesda National Institute of Diabetes and Digestive and Kidney Dis… Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease NCT06989320NA2 sites📍 Birmingham📍 Dallas University of Alabama at Birmingham · Tests: Low-oxalate diet and glycolate dosing, Oral glycolate dosing, Oral 13C- ascorbic acid dosing A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort NCT07024823Phase 15 sites📍 Glendale📍 Chicago📍 Ann Arbor AstraZeneca · Tests: AZD4248, Placebo, AZD4248, Placebo OCTA in Cardiovascular Disease and Healthy Controls NCT07359664NA1 site📍 Erlangen University of Erlangen-Nürnberg Medical School · Tests: Retinal vascular assessment using OCTA and SLDF Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Adults With and Without Androgenetic Alopecia NCT07317544Phase 1, Phase 24 sites📍 Sydney📍 Brisbane📍 Melbourne Absci Pty Ltd. · Tests: SAD IV Dose 1 - 150mg ABS201 IV Single Dose, Placebo IV, ABS-201 SC Multiple Doses, Placebo SC Injection
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy